Research Article
Investigation of Anti-Toxocara and Anti-Toxoplasma Antibodies in Patients with Schizophrenia Disorder
Table 8
The distribution of toxocariasis according to the age in patients with schizophrenia disorder and healthy controls.
| | Patients’ group | Healthy | Sig | OR | CI95 | | (%) | (%) |
| Age (years) | | | | | | <20 | 0 (0%) | 0 (0%) | | | | 20–29 | 4/32 (12.5%) | 3/83 (4.81%) | 0.1 | 2.9 | 0.68–12.5 | 30–39 | 6/34 (17.14%) | 1/7 (14.28%) | 0.6 | 1.2 | 0.12–12.2 | 40–49 | 2/23 (8.69%) | 0/0 (0%) | | | | >50 | 2/11 (18.18%) | 0/1 (0%) | 0.8 | 0.81 | 0.61–1.08 |
|
|